Horizon Pharma (HZNP)
18.01
-0.77 -4.10%
NASDAQ
Sep 29, 14:40
Delayed 2m
USD
View All Key Stats
HZNP Key Stats
| Income Statement | |
| Revenue (TTM) | 933.15M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.02 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -3.151M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.48% |
| Profit Margin (Quarterly) | 5.82% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 2.898B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 3.148 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 2.166 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.8546 |
| Free Cash Flow (Quarterly) | 42.05M |
| Return on Equity (TTM) | -0.24% |
View All HZNP News
HZNP News
-
WireHeadlineTime (ET)
-
MT Newswires09/29 14:15
-
MT Newswires09/29 12:41
-
MT Newswires09/29 11:18
-
Globe Newswire09/29 08:00
-
Yahoo09/27 13:30
-
Yahoo09/22 08:04
-
Yahoo09/21 12:14
-
Yahoo09/21 11:05
-
Yahoo09/21 10:04
-
Yahoo09/21 08:04
View All Events
HZNP Events
| Date | Type | Description |
|---|---|---|
| 08/08/2016 08:00 EDT | Misc | Horizon Pharma PLC Second Quarter Earnings Conference Call in 2016 |
| 08/08/2016 | Earnings | Horizon Pharma PLC Second Quarter Earnings in 2016 Release |
| 11/06/2015 08:00 EST | Misc | Horizon Pharma PLC Third Quarter Earnings Conference Call in 2015 |
| 11/06/2015 | Earnings | Horizon Pharma PLC Third Quarter Earnings in 2015 Release |
HZNP Fundamentals
Income Statement View Statement
HZNP Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.horizonpharma.com
- Investor Relations URL: http://ir.horizon-pharma.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: N/A
- Last Earnings Release: August 08, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Horizon Pharma PLC is a specialty pharmaceutical company. The Company's product portfolio consists of ACTIMMUNE, DUEXIS, PENNSAID 2% and RAYOS/LODOTRA, which addresses the unmet therapeutic needs in arthritis, pain, inflammatory and/or orphan diseases.
HZNP Comparables
EditHZNP Excel Add-In Codes
- Name: =YCI("HZNP","name")
- Description: =YCI("HZNP","description")
- Sector: =YCI("HZNP","sector")
- Industry: =YCI("HZNP","industry")
- Est. Current Fiscal Year End: =YCI("HZNP","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other HZNP Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- HZNP Tweets Stocktwits
Advertisement